ADGRG2 and leiomyosarcoma: In this study, GPR64 cDNA positivity was 71.4% for Ewing sarcoma, 60% for UPS, 75% for leiomyosarcoma, 85.7% for dedifferentiated liposarcoma, and 71.4% for synovial sarcoma.